Le Lézard
Classified in: Covid-19 virus
Subject: OBI

COVID-19 related death of an inmate


INNISFAIL, AB, May 12, 2021 /CNW/ - Correctional Service Canada

On May 11, 2021, an inmate from Bowden Institution died as an apparent result of complications related to COVID-19.

The inmate's next of kin have been notified of their death. The Correctional Service of Canada (CSC) extends its condolences to the family.

As in all cases involving the death of an inmate, CSC has notified the coroner who will review the circumstances of the death.

CSC has dedicated health services and medical professionals in all of its institutions. We also work closely and collaboratively with local public heath partners and hospitals to provide complete and quality medical care to those who need it and to prevent further spread of COVID-19.

This is the sixth death related to COVID-19 among federally sentenced inmates. CSC provides regular updates on COVID-19 tests and cases among federal offenders in institutions.

The Privacy Act allows CSC to release certain information at the time of a death in custody. To provide transparency during this pandemic, CSC is disclosing the deaths linked to COVID-19 while respecting privacy and the protection of personal information by not disclosing the name of the inmate or their personal medical details.

Quick Facts

Associated links

CSC Website
Inmate COVID-19 Testing at Federal Correctional Institutions
CSC COVID-19 Vaccine Roll-Out: Phase Two
CSC COVID-19 Preparedness and Plans
Bowden Institution

SOURCE Correctional Services of Canada Prairie Region


These press releases may also interest you

at 22:00
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: